Keywords: Poland, Drug distribution, Wholesalers, M&A
Poland’s pharma distribution seeing many changes, with significant consolidation among wholesalers
Article | 9 February 2010
In recent years, the pharmaceutical distribution market in Poland has seen many changes. The wholesale distribution segment has experienced consolidation, including combinations between leading players, as well as the privatization of State Treasury outlets. New forms of distribution have also been developed, such as direct/DTP distribution.
According to the latest report by the local research and consulting company PMR, titled “Distribution on the pharmaceutical market in Poland 2010: Development forecasts for 2010-2012,” during the 2008-2009 period, the pharmaceutical distribution sector in Poland saw further consolidation, both among distributors and among retailers. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.
FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!
Sign up in less than 60 seconds...no payment needed
Want to read the full article?
Take a 30 day FREE Trial worth £60
Take a no obligations 30 day trial.
Only one trial per user. Find out more details
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Pfizer acts to stop Mylan marketing generic Chantix; Allergan in $600 million settlement over Botox marketing practices
- PDL BioPharma sues Roche’s Genentech over royalties
- Novartis/NIH-sponsored research yields promising malaria drug candidate
- Indian’s Ranbaxy inaugurates new $30 million drug manufacturing facility in South Africa
- Seattle Genetics gets milestone as Astellas unit moves cancer drug into Ph I
